相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
S. Narla et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance
John W. Frew et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial
Rachel G. Casseres et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa
L. Prussick et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases
Angelo V. Marzano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease
Megan Hohenberger et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2018)
T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities
B. C. Melnik et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
Lukasz Matusiak et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)